Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Roxadustat Conversion in Subjects Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04484857
Recruitment Status : Active, not recruiting
First Posted : July 24, 2020
Last Update Posted : April 22, 2021
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
FibroGen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 31, 2021
Estimated Study Completion Date : August 28, 2021